Avsola (infliximab-axxq) is used to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, Crohn's disease, plaque psoriasis and ulcerative colitis. Avsola is a biosimilar for remicade (infliximab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Avsola may be covered by your Medicare or insurance plan.

With the Patient Assistance Program from Amgen, you can receive your medication free of charge for up to one year.